Package 68999-706-24

{"route": ["ORAL"], "spl_id": "476c3997-b596-17d2-e063-6394a90a6ca1", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["199148"], "spl_set_id": ["b23aea53-324b-4ff2-8736-639e4045e388"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Chartwell Govermental & Specialty RX, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TRAY in 1 BOX (68999-706-24)  / 10 CUP in 1 TRAY / 30 mL in 1 CUP (68999-706-30)", "package_ndc": "68999-706-24", "marketing_start_date": "20251224"}], "brand_name": "lamivudine", "product_id": "68999-706_476c3997-b596-17d2-e063-6394a90a6ca1", "dosage_form": "SOLUTION", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "68999-706", "generic_name": "lamivudine oral", "labeler_name": "Chartwell Govermental & Specialty RX, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "10 mg/mL"}], "application_number": "ANDA203564", "marketing_category": "ANDA", "marketing_start_date": "20141031", "listing_expiration_date": "20271231"}